Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery

被引:1
作者
Ge, Tony [1 ]
Cintrat, Jean-Christophe [1 ]
机构
[1] Univ Paris Saclay, CEA, SCBM, INRAE,Dept Medicaments & Technol Sante DMTS, F-91191 Gif Sur Yvette, France
关键词
pyrrolotriazinone; heterocycle; inhibitor; antagonist; EP3; RECEPTOR; ANTAGONISTS; INHIBITOR; VIVO;
D O I
10.3390/ph14121275
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Heterocyclic amino derivatives have been extensively synthesized and validated as potent bioactive compounds, and nowadays, numerous marketed drugs share these scaffolds, from very simple structures (monoamino, monocyclic compounds) to much more complex molecules (polycyclic derivatives with two or more nitrogen atoms within the (fused) rings). In a constant quest for new chemical entities in drug discovery, a few novel heterocycles have emerged in recent years as promising building blocks for the obtainment of bioactive modulators. In this context, pyrrolotriazinones have attracted attention, and some show promising biological activities. Here, we offer an extensive review of pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one and pyrrolo[1,2-d][1,2,4]triazin-4(3H)-one, describing their biological properties en route to drug discovery.
引用
收藏
页数:13
相关论文
共 44 条
[1]  
Candish L., 2021, WO Patent, Patent No. [WO2021094209A1, 2021094209]
[2]   Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy [J].
Cartel, Maelle ;
Mouchel, Pierre-Luc ;
Gotanegre, Mathilde ;
David, Laure ;
Bertoli, Sarah ;
Mansat-De Mas, Veronique ;
Besson, Arnaud ;
Sarry, Jean-Emmanuel ;
Manenti, Stephane ;
Didier, Christine .
LEUKEMIA, 2021, 35 (02) :417-432
[3]   Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability [J].
Cipollone, F ;
Prontera, C ;
Pini, B ;
Marini, M ;
Fazia, M ;
De Cesare, D ;
Iezzi, A ;
Ucchino, S ;
Boccoli, G ;
Saba, V ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2001, 104 (08) :921-927
[4]   Mechanisms of action of PDE5 inhibition in erectile dysfunction [J].
Corbin, JD .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (Suppl 1) :S4-S7
[5]   Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studies [J].
Devasthale, Pratik ;
Wang, Wei ;
Mignone, James ;
Renduchintala, Kishore ;
Radhakrishnan, Sridhar ;
Dhanapal, Jayanthi ;
Selvaraj, Jagannath ;
Kuppusamy, Rajesh ;
Pelleymounter, Mary Ann ;
Longhi, Daniel ;
Huang, Ning ;
Flynn, Neil ;
Azzara, Anthony V. ;
Rohrbach, Kenneth ;
Devenny, James ;
Rooney, Suzanne ;
Thomas, Michael ;
Godonis, Helen ;
Harvey, Susan ;
Cullen, Mary Jane ;
Zhang, Hongwei ;
Caporuscio, Christian ;
Stetsko, Paul ;
Grubb, Mary ;
Huang, Christine ;
Zhang, Lisa ;
Freeden, Chris ;
Murphy, Brian J. ;
Robl, Jeffrey A. ;
Washburn, William N. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (20) :4412-4418
[6]   PI3K Inhibitors in Breast Cancer Therapy [J].
Ellis, Haley ;
Ma, Cynthia X. .
CURRENT ONCOLOGY REPORTS, 2019, 21 (12)
[7]   Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases [J].
Erra, Montse ;
Taltavull, Joan ;
Javier Bernal, Francisco ;
Francisco Caturla, Juan ;
Carrascal, Marta ;
Pages, Lluis ;
Mir, Marta ;
Espinosa, Sonia ;
Gracia, Jordi ;
Dominguez, Maria ;
Sabate, Mar ;
Paris, Stephane ;
Maldonado, Monica ;
Hernandez, Begona ;
Bravo, Monica ;
Calama, Elena ;
Miralpeix, Montserrat ;
Lehner, Martin D. ;
Calbet, Marta .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (21) :9551-9567
[8]   Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases [J].
Erra, Montse ;
Taltavull, Joan ;
Greco, Angelique ;
Javier Bernal, Francisco ;
Francisco Caturla, Juan ;
Gracia, Jordi ;
Dominguez, Maria ;
Sabate, Mar ;
Paris, Stephane ;
Soria, Salome ;
Hernandez, Begona ;
Armengol, Clara ;
Cabedo, Judit ;
Bravo, Monica ;
Calama, Elena ;
Miralpeix, Montserrat ;
Lehner, Martin D. .
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (01) :118-123
[9]   Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y12 antagonist both in-vitro and ex-vivo in human volunteers [J].
Fox, S. C. ;
May, J. A. ;
Johnson, A. ;
Hermann, D. ;
Strieter, D. ;
Hartman, D. ;
Heptinstall, S. .
PLATELETS, 2013, 24 (05) :392-400
[10]   Sepiapterin Reductase Inhibition Leading to Selective Reduction of Inflammatory Joint Pain in Mice and Increased Urinary Sepiapterin Levels in Humans and Mice [J].
Fujita, Masahide ;
Scheffer, Debora da Luz ;
Turnes, Bruna Lenfers ;
Cronin, Shane J. F. ;
Latremoliere, Alban ;
Costigan, Michael ;
Woolf, Clifford J. ;
Latini, Alexandra ;
Andrews, Nick A. .
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (01) :57-66